AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca money market funds ($) ($)
Form 11-K Fair Value Hierarchy Note
Latest, FY2025
12,491,023
Period ended Dec 31, 2025
Change on a year earlier
-32.1%
18,400,867 in FY2024
History
7 years
Since FY2019
Sources
6
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Money market funds ($) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 12,491,023 | -32.1% | Form 11-K FY2025 (AstraZeneca US 401(k) Plan) ↗ |
| FY2024 | Dec 31, 2024 | 18,400,867 | -91.0% | Form 11-K FY2025 (AstraZeneca US 401(k) Plan) ↗ |
| FY2023 | Dec 31, 2023 | 204,506,241 | +14.2% | Form 11-K FY2024 (AstraZeneca US 401(k) Plan) ↗ |
| FY2022 | Dec 31, 2022 | 179,148,040 | +17.0% | Form 11-K FY2023 (AstraZeneca US 401(k) Plan) ↗ |
| FY2021 | Dec 31, 2021 | 153,103,269 | -18.1% | Form 11-K FY2022 (AstraZeneca US 401(k) Plan) ↗ |
| FY2020 | Dec 31, 2020 | 186,858,854 | +22.1% | Form 11-K FY2021 (AstraZeneca US 401(k) Plan) ↗ |
| FY2019 | Dec 31, 2019 | 152,986,740 | – | Form 11-K FY2020 (AstraZeneca US 401(k) Plan) ↗ |
Cite this data
StockData. (2026). AstraZeneca Money market funds ($) ($), annual FY2019–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/plan11k_fv_money_mkt
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.